+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laboratory and clinical studies of aztreonam in the pediatric field



Laboratory and clinical studies of aztreonam in the pediatric field



Japanese Journal of Antibiotics 38(11): 3300-3306



The authors have carried out the laboratory and clinical studies of aztreonam (AZT) and obtained the following results. The antibacterial activities of AZT against the clinical isolates of E. coli, K. pneumoniae and P. aeruginosa were measured by the agar dilution method with inoculum size of 10(6) cells/ml. The susceptibility distribution of E. coli to AZT ranged from 0.025 or lower to 1.56 microgram/ml, and the peak of distribution was 0.05 microgram/ml. The peak of susceptibility distribution of K. pneumoniae was 0.025 microgram/ml or lower, and the distribution of P. aeruginosa ranged from 0.1 to 100 micrograms/ml higher and the peak of distribution was 3.13 micrograms/ml. After intravenous bolus injection of 20 mg of AZT in 4 children, the mean peak serum level was 117 +/- 35.1 micrograms/ml at 15 minutes after injection, and half-life time was 1.42 hours. The mean urinary excretion rates was 63.2 +/- 30.6% up to 6 hours after bolus injection of 20 mg/kg of AZT. AZT was given 11 cases with bacterial injection. Daily doses of AZT were from 41.7 to 94.9 mg/kg. Clinical results obtained were excellent and good responses in 8 of 11 cases (72.7%). No side effect was observed.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005787323

Download citation: RISBibTeXText

PMID: 4094062


Related references

Laboratory and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3343-3348, 1985

Fundamental and clinical studies of aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3239-3262, 1985

Bacteriological pharmacokinetic and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3195-3216, 1985

Clinical experience with aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3316-3322, 1985

Laboratory and clinical studies of PC-904 in pediatric field. Japanese Journal of Antibiotics 31(7): 359-362, 1978

Laboratory and clinical studies of cefuzonam in pediatric field. Japanese Journal of Antibiotics 40(2): 427-438, 1987

Laboratory and clinical studies of cefoperazone in pediatric field. Japanese Journal of Antibiotics 33(9): 899-909, 1980

Laboratory and clinical studies of sultamicillin in pediatric field. Japanese Journal of Antibiotics 41(12): 1923-1939, 1988

Laboratory and clinical studies of ceftazidime in the pediatric field. Japanese Journal of Antibiotics 37(3): 512-523, 1984

Laboratory and clinical studies on cefdinir in pediatric field. Japanese Journal of Antibiotics 43(8): 1424-1435, 1990

Laboratory and clinical studies on cefamandole in pediatric field. Japanese Journal of Antibiotics 32(11): 1091-1100, 1979

Laboratory and clinical studies on cefodizime in the pediatric field. Japanese Journal of Antibiotics 42(6): 1424-1435, 1989

Laboratory and clinical studies cefroxadine in pediatric field. Japanese Journal of Antibiotics 34(12): 1655-1662, 1981

Laboratory and clinical studies of 6059-S in pediatric field. Japanese Journal of Antibiotics 34(5): 800-816, 1981

Laboratory and clinical studies on norfloxacin in the pediatric field. Japanese Journal of Antibiotics 43(5): 808-825, 1990